Recherche
Publications

Liste complète des publications 2014-2019

Rubira L, Leenhardt F, Perrier C, Pinguet F [Securing the patient's care path receiving oral anticancer therapy: Experimentation around a pharmaceutical hospital-to-community liaison]. Ann Pharm Fr. 2021-02-04. doi:10.1016/j.pharma.2021.01.009

Franchet C, Djerroudi L, Maran-Gonzalez A, Abramovici O, Antoine M, Berghian A, Blanc-Fournier C, Brabencova E, Charafe-Jauffret E, Chenard M-P, Dauplat M-M, Delrée P, Fleury C, Ghnassia J-P, Haudebourg J, Leroux A, Mathieu M-C, Michenet P, Penault-Llorca F, Poulet B, Robin Y, Roger P, Russ E, Tixier L, Treilleux I, Valent A, Verriele V, Vincent-Salomon A, Arnould L, Lacroix-Triki M [2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France]. Ann Pathol. 2021-08-12. doi:10.1016/j.annpat.2021.07.014

Deshayes E, Fersing C, Hébert K, Kotzki P, Santoro L Whole body planar and 3D quantitative imaging after 177Lu-DOTATATE on CZT SPECT/CT device with MEHRS collimator. First report. Hell J Nucl Med. 2021;24(2):165-166. doi:10.1967/s002449912361

Culié D, Viotti J, Modesto A, Schiappa R, Chamorey E, Dassonville O, Poissonnet G, Guelfucci B, Bizeau A, Vergez S, Dupret-Bories A, Garrel R, Fakhry N, Santini L, Lallemant B, Chambon G, Sudaka A, Peyrade F, Saada-Bouzid E, Benezery K, Jourdan-Soulier F, Chapel F, Ramay A, Roger P, Galissier T, Coste V, Ben Lakdar A, Guerlain J, Temam S, Mirghani H, Gorphe P, Bozec A Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric study. Eur J Surg Oncol. 2021;47(2):367-374. doi:10.1016/j.ejso.2020.07.034

Renosi F, Roggy A, Giguelay A, Soret L, Viailly P-J, Cheok M, Biichle S, Angelot-Delettre F, Asnafi V, Macintyre E, Geffroy S, Callanan M, Petrella T, Deconinck E, Daguindau E, Harrivel V, Bouyer S, Salaun V, Saussoy P, Feuillard J, Fuseau P, Saas P, Adotévi O, Jardin F, Ferrand C, Preudhomme C, Colinge J, Roumier C, Garnache-Ottou F Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis. Blood Adv. 2021;5(5):1540-1551. doi:10.1182/bloodadvances.2020003359

Arnaudguilhem C, Larroque M, Sgarbura O, Michau D, Carrère S, Mounicou S Toward a comprehensive study for multielemental quantitative LA-ICP MS bioimaging in soft tissues. Talanta. 2021;222. doi:10.1016/j.talanta.2020.121537

Rittore C, Méchin D, Sanchez E, Marinèche L, Ea V, Soler S, Vereecke M, Mallavialle A, Richard E, Duroux-Richard I, Apparailly F, Touitou I, Grandemange S TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNF?/TNFR1 signalling regulation in the pathophysiology of TRAPS. 2021;11(1):4172. doi:10.1038/s41598-021-83539-9

Kusamura S, Barretta F, Yonemura Y, Sugarbaker P, Moran B, Levine E, Goere D, Baratti D, Nizri E, Morris D, Glehen O, Sardi A, Barrios P, Quénet F, Villeneuve L, Gómez-Portilla A, de Hingh I, Ceelen W, Pelz J, Piso P, González-Moreno S, Van Der Speeten K, Deraco M The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery. JAMA Surg. 2021-01-27. doi:10.1001/jamasurg.2020.6363

Lahalle A, Lacroix M, De Blasio C, Cissé M, Linares L, Le Cam L The p53 Pathway and Metabolism: The Tree That Hides the Forest. Cancers. 2021;13(1):133. doi:10.3390/cancers13010133

Colin F, Schauer K, Hamiche A, Martineau P, Borg J-P, Bednar J, Bertolin G, Camoin L, Collette Y, Dimitrov S, Fournier I, Hyenne V, Mendoza-Parra M, Morelli X, Rondé P, Sumara I, Tramier M, Schultz P, Goetz J The NANOTUMOR consortium - Towards the Tumor Cell Atlas. Biol Cell. 2021-02-07. doi:10.1111/boc.202000135

Cornillot E, Cacheux V, Rigau V, Costes-Martineau V, Lacheretz-Szablewski V, Colinge J The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling. Theranostics. 2021;11(8):3565-3579. doi:10.7150/thno.54343

Idrissou M, Pichard A, Tee B, Kibedi T, Poty S, Pouget J-P Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide. Pharmaceutics. 2021;13(7):980. doi:10.3390/pharmaceutics13070980

Milliet F, Bozec A, Schiappa R, Viotti J, Modesto A, Dassonville O, Poissonnet G, Guelfucci B, Bizeau A, Vergez S, Dupret-Bories A, Garrel R, Fakhry N, Santini L, Lallemant B, Chambon G, Sudaka A, Peyrade F, Saada-Bouzid E, Benezery K, Jourdan-Soulier F, Chapel F, Sophie Ramay A, Roger P, Galissier T, Coste V, Ben Lakdar A, Guerlain J, Temam S, Mirghani H, Gorphe P, Chamorey E, Culié D Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric study. Oral Oncol. 2021;112. doi:10.1016/j.oraloncology.2020.105041

Larroque M, Mounicou S, Sgarbura O, Arnaudguilhem C, Rebel L, Leaha C, Faye P-A, Enjalbal C, Quénet F, Bouyssiere B Study of oxaliplatin penetration into ovaries of patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastases of colorectal and appendiceal origin using mass spectrometry imaging. Pleura Peritoneum. 2021;6(2):67-74. doi:10.1515/pp-2020-0149

Xiong H, Mancini M, Gobert M, Shen S, Furtado G, Lira S, Parkhurst C, Brengues M, Tadokoro C, Trimarchi T, Singh A, Khiabanian H, Minuzzo S, Indraccolo S, Lobry C, Aifantis I, Herranz D, Lafaille J, Maraver A Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia. Theranostics. 2021;11(4):1594-1608. doi:10.7150/thno.48067

Gear J Scientific Developments in Imaging and Dosimetry for Molecular Radiotherapy. Clin Oncol (R Coll Radiol). 2021;33(2):117-124. doi:10.1016/j.clon.2020.11.005

Gleizes A, Triki M, Bonnet S, Baccari N, Jimenez-Dominguez G, Covinhes A, Pirot N, Blache P, Yuan R, Gy?rffy B, Cavaillès V, Lapierre M RIP140 Represses Intestinal Paneth Cell Differentiation and Interplays with SOX9 Signaling in Colorectal Cancer. Cancers (Basel). 2021;13(13):3192. doi:10.3390/cancers13133192

Pouget J-P, Constanzo J Revisiting the Radiobiology of Targeted Alpha Therapy. Front Med (Lausanne). 2021;8. doi:10.3389/fmed.2021.692436

Boisselier P, Flori N, Vinches M, Bourhis J, Senesse P Reply to Caccialanza et al. Am J Clin Nutr. 2021;113(4):1054-1055. doi:10.1093/ajcn/nqaa425

Cousin S, Cantarel C, Guégan J-P, Gomez-Roca C, Metges J-P, Adenis A, Pernot S, Bellera C, Kind M, Auzanneau C, Soubeyran I, Bessede A, Italiano A Regorafenib-Avelumab combination in patients with microsatellite stable colorectal cancer (REGOMUNE) : a single arm, open-label, phase II trial. Clin Cancer Res. 2021-01-25. doi:10.1158/1078-0432.CCR-20-3416

Bertho M, Fraisse J, Patsouris A, Cottu P, Arnedos M, Pérol D, Jaffré A, Goncalves A, Lebitasy M-P, D'Hondt V, Dalenc F, Ferrero J-M, Levy C, Dabakuyo S, Rouzier R, Penault-Llorca F, Uwer L, Eymard J-C, Breton M, Chevrot M, Thureau S, Petit T, Simon G Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program. Ther Adv Med Oncol. 2021;13. doi:10.1177/1758835920987657

Karam J, Constanzo J, Pichard A, Gros L, Chopineau J, Morille M, Pouget J-P Rapid communication: insights into the role of extracellular vesicles during Auger radioimmunotherapy. Int J Radiat Biol. 2021-07-26. doi:10.1080/09553002.2021.1955999

Constanzo J, Faget J, Ursino C, Badie C, Pouget J-P Radiation-Induced Immunity and Toxicities: The Versatility of the cGAS-STING Pathway. Front Immunol. 2021;12. doi:10.3389/fimmu.2021.680503

Aptecar L, Fiteni F, Jarlier M, Guillerme V, Jacot W Prospective evaluation of sexual health in breast cancer women during the first year of adjuvant hormonal treatment using a cancer patient's dedicated questionnaire: A glaring gap of communication between health professionals and patients. Breast Cancer Res Treat. 2021-01-15. doi:10.1007/s10549-020-06062-x

Assenat E, Mineur L, Mollevi C, Lopez-Crapez E, Lombard-Bohas C, Samalin E, Portales F, Walter T, de Forges H, Dupuy M, Boissière-Michot F, Ho-Pun-Cheung A, Ychou M, Mazard T Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first-line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1). Int J Cancer. 2021;148(3):682-691. doi:10.1002/ijc.33225



© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés